Moller I, Largo R, Bong D, Filer A, Najm A, Alivernini S
RMD Open. 2025; 11(1.
PMID: 39832957
PMC: 11749067.
DOI: 10.1136/rmdopen-2024-005065.
Garaffoni C, Tamussin M, Calciolari I, Lanza G, Bortoluzzi A, Scire C
Front Immunol. 2024; 14:1298583.
PMID: 38274811
PMC: 10808827.
DOI: 10.3389/fimmu.2023.1298583.
Andreozzi V, Monaco E, Garufi C, Spinelli F, Rossi G, Dagget M
Arthrosc Sports Med Rehabil. 2022; 4(6):e2099-e2106.
PMID: 36579034
PMC: 9791868.
DOI: 10.1016/j.asmr.2022.10.003.
Fuentes-Braesch M, Tuijthof G, Emans P, Emanuel K
Rheumatol Int. 2022; 43(10):1767-1779.
PMID: 36513849
DOI: 10.1007/s00296-022-05256-4.
Anang D, Ramwadhdoebe T, Hahnlein J, van Kuijk B, Smits N, van Lienden K
Cells. 2022; 11(7).
PMID: 35406668
PMC: 8997933.
DOI: 10.3390/cells11071104.
From Bed to Bench and Back: TNF-α, IL-23/IL-17A, and JAK-Dependent Inflammation in the Pathogenesis of Psoriatic Synovitis.
Silvagni E, Missiroli S, Perrone M, Patergnani S, Boncompagni C, Bortoluzzi A
Front Pharmacol. 2021; 12:672515.
PMID: 34211394
PMC: 8241099.
DOI: 10.3389/fphar.2021.672515.
IL-12p40/IL-23p40 Blockade With Ustekinumab Decreases the Synovial Inflammatory Infiltrate Through Modulation of Multiple Signaling Pathways Including MAPK-ERK and Wnt.
Fiechter R, de Jong H, van Mens L, Fluri I, Tas S, Baeten D
Front Immunol. 2021; 12:611656.
PMID: 33746955
PMC: 7971179.
DOI: 10.3389/fimmu.2021.611656.
A randomized, placebo-controlled experimental medicine study of RIPK1 inhibitor GSK2982772 in patients with moderate to severe rheumatoid arthritis.
Weisel K, Berger S, Thorn K, Taylor P, Peterfy C, Siddall H
Arthritis Res Ther. 2021; 23(1):85.
PMID: 33726834
PMC: 7962407.
DOI: 10.1186/s13075-021-02468-0.
Arthroscopic Guided Synovial Biopsies.
Orr C, Vieira-Sousa E, Fonseca J, Veale D
Front Med (Lausanne). 2021; 7:604582.
PMID: 33681237
PMC: 7928330.
DOI: 10.3389/fmed.2020.604582.
Lower peripheral helper T cell levels in the synovium are associated with a better response to anti-TNF therapy in rheumatoid arthritis.
Julia A, Avila G, Celis R, Sanmarti R, Ramirez J, Marsal S
Arthritis Res Ther. 2020; 22(1):196.
PMID: 32843099
PMC: 7446220.
DOI: 10.1186/s13075-020-02287-9.
Responses to Cytokine Inhibitors Associated with Cellular Composition in Models of Immune-Mediated Inflammatory Arthritis.
Nielsen M, Lomholt S, Mellemkjaer A, Andersen M, Buckley C, Kragstrup T
ACR Open Rheumatol. 2020; 2(1):3-10.
PMID: 31943973
PMC: 6957916.
DOI: 10.1002/acr2.11094.
Overweight/obesity affects histological features and inflammatory gene signature of synovial membrane of Rheumatoid Arthritis.
Alivernini S, Tolusso B, Gigante M, Petricca L, Bui L, Fedele A
Sci Rep. 2019; 9(1):10420.
PMID: 31320744
PMC: 6639364.
DOI: 10.1038/s41598-019-46927-w.
Synovial Tissue: Turning the Page to Precision Medicine in Arthritis.
Triaille C, Lauwerys B
Front Med (Lausanne). 2019; 6:46.
PMID: 30949482
PMC: 6437087.
DOI: 10.3389/fmed.2019.00046.
Synovial Tissue Sampling in Rheumatological Practice-Past Developments and Future Perspectives.
Humby F
Front Med (Lausanne). 2019; 6:4.
PMID: 30761301
PMC: 6361834.
DOI: 10.3389/fmed.2019.00004.
Ultrasound-Guided Synovial Biopsies of Wrists, Metacarpophalangeal, Metatarsophalangeal, Interphalangeal Joints, and Tendon Sheaths.
Lazarou I, Kelly S, Meric de Bellefon L
Front Med (Lausanne). 2019; 6:2.
PMID: 30719434
PMC: 6348247.
DOI: 10.3389/fmed.2019.00002.
Standardisation of synovial biopsy analyses in rheumatic diseases: a consensus of the EULAR Synovitis and OMERACT Synovial Tissue Biopsy Groups.
Najm A, Le Goff B, Orr C, Thurlings R, Canete J, Humby F
Arthritis Res Ther. 2018; 20(1):265.
PMID: 30509322
PMC: 6276172.
DOI: 10.1186/s13075-018-1762-1.
Patient-reported outcomes and safety in patients undergoing synovial biopsy: comparison of ultrasound-guided needle biopsy, ultrasound-guided portal and forceps and arthroscopic-guided synovial biopsy techniques in five centres across Europe.
Just S, Humby F, Lindegaard H, Meric de Bellefon L, Durez P, Vieira-Sousa E
RMD Open. 2018; 4(2):e000799.
PMID: 30488001
PMC: 6241983.
DOI: 10.1136/rmdopen-2018-000799.
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA.
Frasca L, Palazzo R, Chimenti M, Alivernini S, Tolusso B, Bui L
Front Immunol. 2018; 9:1936.
PMID: 30279686
PMC: 6154218.
DOI: 10.3389/fimmu.2018.01936.
Control of cytokine mRNA degradation by the histone deacetylase inhibitor ITF2357 in rheumatoid arthritis fibroblast-like synoviocytes: beyond transcriptional regulation.
Angiolilli C, Kabala P, Grabiec A, Rossato M, Lai W, Fossati G
Arthritis Res Ther. 2018; 20(1):148.
PMID: 30029685
PMC: 6053802.
DOI: 10.1186/s13075-018-1638-4.
Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis.
Alivernini S, Pugliese D, Tolusso B, Bui L, Petricca L, Guidi L
RMD Open. 2018; 4(1):e000667.
PMID: 29657833
PMC: 5892785.
DOI: 10.1136/rmdopen-2018-000667.
